UroGen Pharma Ltd.
URGN
$29.80
-$1.53-4.88%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.39% | -49.11% | -49.10% | -34.89% | 19.41% |
| Total Receivables | 182.17% | 62.95% | -13.59% | 12.83% | 38.71% |
| Inventory | 175.64% | 78.43% | 9.84% | -4.22% | 4.79% |
| Prepaid Expenses | 50.43% | 65.88% | -13.74% | -1.25% | 23.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 23.33% | 25.46% | 25.54% | 31.15% | 30.74% |
| Total Current Assets | 0.12% | -32.63% | -42.88% | -29.43% | 20.54% |
|
|
|||||
| Total Current Assets | 0.12% | -32.63% | -42.88% | -29.43% | 20.54% |
| Net Property, Plant & Equipment | 59.03% | 139.98% | 453.25% | 240.93% | 167.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,302.19% | 597.78% | 1,172.66% | 15.33% | -58.69% |
| Total Assets | 2.45% | -29.84% | -38.71% | -25.95% | 23.45% |
|
|
|||||
| Total Accounts Payable | 18.14% | 11.03% | 85.01% | 63.09% | 132.74% |
| Total Accrued Expenses | 23.11% | 7.48% | 16.62% | 30.32% | 34.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.50% | 14.71% | 92.48% | 94.47% | 81.51% |
| Total Finance Division Other Current Liabilities | 7.25% | -46.56% | 3.73% | 20.11% | 36.35% |
| Total Other Current Liabilities | 7.25% | -46.56% | 3.73% | 20.11% | 36.35% |
| Total Current Liabilities | 20.56% | 1.02% | 28.84% | 38.94% | 59.45% |
|
|
|||||
| Total Current Liabilities | 20.56% | 1.02% | 28.84% | 38.94% | 59.45% |
| Long-Term Debt | 55.22% | 0.39% | 0.33% | 25.25% | 25.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 98.77% | 270.36% | 2,843.87% | 703.06% | 346.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.94% | 4.79% | 6.69% | 8.02% | 9.46% |
| Total Liabilities | 28.52% | 3.88% | 8.69% | 20.10% | 22.17% |
|
|
|||||
| Common Stock & APIC | 6.90% | 7.13% | 3.01% | 4.03% | 19.66% |
| Retained Earnings | -15.67% | -19.04% | -21.42% | -20.80% | -19.45% |
| Treasury Stock & Other | -42.86% | -66.07% | -90.25% | 119.35% | 137.84% |
| Total Common Equity | -167.45% | -1,098.16% | -552.31% | -408.03% | -15.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -167.45% | -1,098.16% | -552.31% | -408.03% | -15.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -167.45% | -1,098.16% | -552.31% | -408.03% | -15.76% |
|
|
|||||